切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2019, Vol. 08 ›› Issue (03) : 196 -201. doi: 10.3877/cma.j.issn.2095-3232.2019.03.005

所属专题: 文献

专家论坛

自身免疫性胰腺炎的诊断与治疗
赵过超1, 吴文川1,()   
  1. 1. 200032 上海,复旦大学附属中山医院普通外科
  • 收稿日期:2019-03-15 出版日期:2019-06-10
  • 通信作者: 吴文川
  • 基金资助:
    上海市浦江人才计划(16PJD013)

Treatments and diagnosis of autoimmune pancreatitis

Guochao Zhao1, Wenchuan Wu1()   

  • Received:2019-03-15 Published:2019-06-10
  • Corresponding author: Wenchuan Wu
引用本文:

赵过超, 吴文川. 自身免疫性胰腺炎的诊断与治疗[J]. 中华肝脏外科手术学电子杂志, 2019, 08(03): 196-201.

Guochao Zhao, Wenchuan Wu. Treatments and diagnosis of autoimmune pancreatitis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(03): 196-201.

[1]
Yoshida K,Toki F,Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. proposal of the concept of autoimmune pancreatitis[J]. Dig Dis Sci, 1995, 40(7):1561-1568.
[2]
Okazaki K,Kawa S,Kamisawa T, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 I. concept and diagnosis of autoimmune pancreatitis[J]. J Gastroenterol, 2014, 49(4):567-588.
[3]
Khosroshahi A,Wallace ZS,Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7):1688-1699.
[4]
Okazaki K,Chari ST,Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis[J]. Pancreatology, 2017, 17(1):1-6.
[5]
Uchida K,Okazaki K. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis[J]. J Gastroenterol, 2018, 53(4):475-483.
[6]
Nagpal SJS,Sharma A,Chari ST. Autoimmune pancreatitis[J]. Am J Gastroenterol, 2018, 113(9):1301-1309.
[7]
Tsen A,Alishahi Y,Rosenkranz L. Autoimmune pancreatitis and inflammatory bowel disease: an updated review[J]. J Clin Gastroenterol, 2017, 51(3):208-214.
[8]
Sah RP,Chari ST. Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management[J]. Curr Gastroenterol Rep, 2012, 14(2):95-105.
[9]
Meng Q,Xin L,Liu W, et al. Diagnosis and treatment of autoimmune pancreatitis in China: a systematic review[J]. PLoS One, 2015, 10(6): e0130466.
[10]
Kamisawa T,Zen Y,Nakazawa T, et al. Advances in IgG4-related pancreatobiliary diseases[J]. Lancet Gastroenterol Hepatol, 2018, 3(8):575-585.
[11]
Morselli-Labate AM,Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis[J]. J Gastroenterol Hepatol, 2009, 24(1):15-36.
[12]
Yan T,Ke Y,Chen Y, et al. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin[J]. PLoS One, 2017, 12(4):e0174735.
[13]
Gu X,Liu R. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly[J]. Clin Interv Aging, 2016(11):1365-1370.
[14]
Sandrasegaran K,Menias CO. Imaging in autoimmune pancreatitis and immunoglobulin G4-related disease of the abdomen[J]. Gastroenterol Clin North Am, 2018, 47(3):603-619.
[15]
Kim M,Jang KM,Kim JH, et al. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping[J]. Eur Radiol, 2017, 27(4):1722-1732.
[16]
Yadav AK,Sharma R,Kandasamy D, et al. Perfusion CT-can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum?[J]. Pancreatology, 2016, 16(6):979-987.
[17]
Zhang TT,Wang L,Liu HH, et al. Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging[J]. Oncotarget, 2017, 8(1):1744-1759.
[18]
Kim JH,Byun JH,Kim MH, et al. Pancreatic duct in autoimmune pancreatitis: intraindividual comparison of magnetic resonance pancreatography at 1.5 T and 3.0 T[J]. Pancreas, 2017, 46(7):921-926.
[19]
Niu XK,Bhetuwal A,Das S, et al. Meta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses[J]. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(6):950-956.
[20]
Dong A,Dong H,Zhang L, et al. Hypermetabolic lesions of the pancreas on FDG PET/CT[J]. Clin Nucl Med, 2013, 38(9):e354-366.
[21]
Kato K,Nihashi T,Ikeda M, et al. Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis[J]. Clin Nucl Med, 2013, 38(6):417-421.
[22]
Zhang J,Jia G,Zuo C, et al. 18F-FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer[J]. BMC Cancer, 2017, 17(1):695.
[23]
Cheng MF,Guo YL,Yen RF, et al. Clinical utility of FDG PET/CT in patients with autoimmune pancreatitis: a case-control study[J]. Sci Rep, 2018, 8(1):3651.
[24]
Fujii-Lau LL,Levy MJ. The role of endoscopic ultrasound in the diagnosis of autoimmune pancreatitis[J]. Gastrointest Endosc Clin N Am, 2017, 27(4):643-655.
[25]
Kamisawa T,Yoshiike M,Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study[J]. Pancreatology, 2005, 5(2/3):234-238.
[26]
Park MK,Jo J,Kwon H, et al. Usefulness of acoustic radiation force impulse elastography in the differential diagnosis of benign and malignant solid pancreatic lesions[J]. Ultrasonography, 2014, 33(1): 26-33.
[27]
Detlefsen S,Mortensen MB,Pless TK, et al. Laparoscopic and percutaneous core needle biopsy plays a central role for the diagnosis of autoimmune pancreatitis in a single-center study from Denmark[J]. Pancreas, 2015, 44(6):845-858.
[28]
Sugimoto M,Takagi T,Suzuki R, et al. Endoscopic ultrasonography-guided fine needle aspiration can be used to rule out malignancy in autoimmune pancreatitis patients[J]. J Ultrasound Med, 2017, 36(11): 2237-2244.
[29]
Ghazale A,Chari ST,Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy[J]. Gastroenterology, 2008, 134(3):706-715.
[30]
Kanno A,Masamune A,Fujishima F, et al. Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle: a prospective multicenter study[J]. Gastrointest Endosc, 2016, 84(5): 797-804, e1.
[31]
Sugumar A,Levy MJ,Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study[J]. Gut, 2011, 60(5):666-670.
[32]
Kamisawa T,Okazaki K,Kawa S, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 III. treatment and prognosis of autoimmune pancreatitis[J]. J Gastroenterol, 2014, 49(6):961-970.
[33]
Buijs J,van Heerde MJ,Rauws EA, et al. Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis[J]. Pancreas, 2014, 43(2):261-267.
[34]
Kamisawa T,Shimosegawa T,Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis[J]. Gut, 2009, 58(11):1504-1507.
[35]
Hart PA,Topazian MD,Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience[J]. Gut, 2013, 62(11):1607-1615.
[36]
Hart PA,Kamisawa T,Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis[J]. Gut, 2013, 62(12):1771-1776.
[37]
Witkiewicz AK,Kennedy EP,Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature[J]. Hum Pathol, 2008, 39(10):1548-1551.
[38]
Ito T,Nakamura T,Fujimori N, et al. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis[J]. J Dig Dis, 2011, 12(3):210-216.
[39]
Lin YK,Johnston PC,Arce K, et al. Chronic pancreatitis and diabetes mellitus[J]. Curr Treat Options Gastroenterol, 2015, 13(3):319-331.
[40]
Working Party of the Australasian Pancreatic Club, Smith RC,Smith SF, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency[J]. Pancreatology, 2016, 16(2):164-180.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 蒋佳纯, 王晓冰, 陈培荣, 许世豪. 血清学指标联合常规超声及超声造影评分诊断原发性干燥综合征的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 622-630.
[3] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[4] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[5] 中华医学会骨科学分会关节外科学组, 广东省医学会骨质疏松和骨矿盐疾病分会, 广东省佛山市顺德区第三人民医院. 中国髋部脆性骨折术后抗骨质疏松药物临床干预指南(2023年版)[J]. 中华关节外科杂志(电子版), 2023, 17(06): 751-764.
[6] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[7] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[8] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[9] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[10] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[11] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[12] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要